MoneyWorks4Me

Saamya Biotech (India) informs about un-audited financial results

23 Feb 2019 Evaluate

Saamya Biotech (India) has informed about submission of un-audited financial results for the second quarter ending 31st December 2018 along with Limited Review Report. The Board Meeting Commenced at 4:00 PM and concluded at 5:00 PM.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1753.95
Dr. Reddys Labs. 1239.00
Cipla 1329.90
Lupin 1928.00
Zydus Lifesciences 1135.00
View more..